Sphinganine

Sphinganine is a lipid of Sphingolipids (SP) class. Sphinganine is associated with abnormalities such as Sphingolipidoses, CLEFT LIP, CONGENITAL HEALED, Aortic aneurysm, familial thoracic 4, Morphologically altered structure and Atherosclerosis. The involved functions are known as Transcription, Genetic, Signal, Muscle Contraction, biological adaptation to stress and Gene Expression. Sphinganine often locates in Tissue membrane, Membrane, Protoplasm, Plasma membrane and Cytoplasmic. The associated genes with Sphinganine are SLC33A1 gene, HM13 gene, P4HTM gene, SPHK1 gene and SPHK2 gene. The related lipids are Sphingolipids, Phosphatidylserines, Sterols, Fatty Acids and inositolphosphorylceramide. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of Sphinganine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphinganine?

Sphinganine is suspected in Pulmonary Edema, Morphologically altered structure, Infection, HIV Infections, Pulmonary Hypertension, Exanthema and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphinganine

MeSH term MeSH ID Detail
Swine Diseases D013553 16 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Body Weight D001835 333 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Total 5

PubChem Associated disorders and diseases

What pathways are associated with Sphinganine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphinganine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphinganine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphinganine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphinganine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphinganine?

Knock-out

Knock-out are used in the study 'Sphingolipids are required for the stable membrane association of glycosylphosphatidylinositol-anchored proteins in yeast.' (Watanabe R et al., 2002) and Knock-out are used in the study 'Role for de novo sphingoid base biosynthesis in the heat-induced transient cell cycle arrest of Saccharomyces cerevisiae.' (Jenkins GM and Hannun YA, 2001).

Mouse Model

Mouse Model are used in the study 'Palmitate increases sphingosine-1-phosphate in C2C12 myotubes via upregulation of sphingosine kinase message and activity.' (Hu W et al., 2009).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphinganine

Download all related citations
Per page 10 20 50 100 | Total 790
Authors Title Published Journal PubMed Link
Dobrzyń A et al. Effect of endurance training on the sphingomyelin-signalling pathway activity in the skeletal muscles of the rat. 2004 J. Physiol. Pharmacol. pmid:15213354
Van IJzendoorn SC et al. Polarized membrane traffic and cell polarity development is dependent on dihydroceramide synthase-regulated sphinganine turnover. 2004 Mol. Biol. Cell pmid:15229289
Batra S et al. Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulators. 2004 Cancer Res. pmid:15289350
Johnson VJ et al. Disruption of sphingolipid homeostasis by myriocin, a mycotoxin, reduces thymic and splenic T-lymphocyte populations. 2004 Toxicology pmid:15297021
Katoh N Inhibition by sulfatide of 21-kDa protein phosphorylation by protein kinase C in cow mammary gland and its reversal by phosphatidylserine. 2004 J. Vet. Med. Sci. pmid:15297754
Kihara A and Igarashi Y FVT-1 is a mammalian 3-ketodihydrosphingosine reductase with an active site that faces the cytosolic side of the endoplasmic reticulum membrane. 2004 J. Biol. Chem. pmid:15328338
Tardieu D et al. Toxicity of maize containing known levels of fumonisin B1 during force-feeding of ducks. 2004 Poult. Sci. pmid:15339002
Sharma N et al. Augmented fumonisin B1 toxicity in co-cultures: evidence for crosstalk between macrophages and non-parenchymatous liver epithelial cells involving proinflammatory cytokines. 2004 Toxicology pmid:15363598
Gopee NV and Sharma RP The mycotoxin fumonisin B1 transiently activates nuclear factor-kappaB, tumor necrosis factor alpha and caspase 3 via protein kinase Calpha-dependent pathway in porcine renal epithelial cells. 2004 Cell Biol. Toxicol. pmid:15499968
Rehman F et al. Fenretinide stimulates redox-sensitive ceramide production in breast cancer cells: potential role in drug-induced cytotoxicity. 2004 Br. J. Cancer pmid:15505623
Yu MU et al. Altered de novo sphingolipid biosynthesis is involved in the serum deprivation-induced cell death in LLC-PK1 cells. 2004 J. Toxicol. Environ. Health Part A pmid:15513905
Park TS et al. Inhibition of sphingomyelin synthesis reduces atherogenesis in apolipoprotein E-knockout mice. 2004 Circulation pmid:15545514
Becker KP et al. Selective inhibition of juxtanuclear translocation of protein kinase C betaII by a negative feedback mechanism involving ceramide formed from the salvage pathway. 2005 J. Biol. Chem. pmid:15546881
Grimm C et al. Activation of the melastatin-related cation channel TRPM3 by D-erythro-sphingosine [corrected]. 2005 Mol. Pharmacol. pmid:15550678
Lee WJ et al. Sphingosine mediates FTY720-induced apoptosis in LLC-PK1 cells. 2004 Exp. Mol. Med. pmid:15557814
Wang JP et al. Stimulation of cellular free Ca2+ elevation and inhibition of store-operated Ca2+ entry by kazinol B in neutrophils. 2004 Naunyn Schmiedebergs Arch. Pharmacol. pmid:15558242
Houjou T et al. Rapid and selective identification of molecular species in phosphatidylcholine and sphingomyelin by conditional neutral loss scanning and MS3. 2004 Rapid Commun. Mass Spectrom. pmid:15565732
Rentz SS et al. Inhibition of sphingolipid biosynthesis decreases phosphorylated ERK2 in LLC-PK1 cells. 2005 Food Chem. Toxicol. pmid:15582204
He Q et al. Fumonisin B1 hepatotoxicity in mice is attenuated by depletion of Kupffer cells by gadolinium chloride. 2005 Toxicology pmid:15590129
Sharma N et al. Sphingosine kinase activity confers resistance to apoptosis by fumonisin B1 in human embryonic kidney (HEK-293) cells. 2004 Chem. Biol. Interact. pmid:15607760
Górska M et al. Concentrations of sphingosine and sphinganine in plasma of patients with type 2 diabetes. 2005 Med. Sci. Monit. pmid:15614193
Sugawara T et al. Efflux of sphingoid bases by P-glycoprotein in human intestinal Caco-2 cells. 2004 Biosci. Biotechnol. Biochem. pmid:15618625
Coursol S et al. Arabidopsis sphingosine kinase and the effects of phytosphingosine-1-phosphate on stomatal aperture. 2005 Plant Physiol. pmid:15665242
Fernández-Surumay G et al. Glucose reaction with fumonisin B1 partially reduces its toxicity in swine. 2004 J. Agric. Food Chem. pmid:15675827
Tran ST et al. Chronic effects of fumonisin B1 on ducks. 2005 Poult. Sci. pmid:15685938
Vallée B and Riezman H Lip1p: a novel subunit of acyl-CoA ceramide synthase. 2005 EMBO J. pmid:15692566
Osuchowski MF et al. Fumonisin B1-induced neurodegeneration in mice after intracerebroventricular infusion is concurrent with disruption of sphingolipid metabolism and activation of proinflammatory signaling. 2005 Neurotoxicology pmid:15713342
Budnik LT and Brunswig-Spickenheier B Differential effects of lysolipids on steroid synthesis in cells expressing endogenous LPA2 receptor. 2005 J. Lipid Res. pmid:15716590
Nagahara Y et al. Phytosphingosine induced mitochondria-involved apoptosis. 2005 Cancer Sci. pmid:15723652
Inagaki Y et al. Sphingosine 1-phosphate analogue recognition and selectivity at S1P4 within the endothelial differentiation gene family of receptors. 2005 Biochem. J. pmid:15733055
Ikeda M et al. Sphingolipid-to-glycerophospholipid conversion in SPL-null cells implies the existence of an alternative isozyme. 2005 Biochem. Biophys. Res. Commun. pmid:15737611
Berdyshev EV et al. Quantitative analysis of sphingoid base-1-phosphates as bisacetylated derivatives by liquid chromatography-tandem mass spectrometry. 2005 Anal. Biochem. pmid:15766719
Cheek S et al. A comprehensive update of the sequence and structure classification of kinases. 2005 BMC Struct. Biol. pmid:15771780
He Q et al. Myriocin prevents fumonisin B1-induced sphingoid base accumulation in mice liver without ameliorating hepatotoxicity. 2005 Food Chem. Toxicol. pmid:15811577
Hsiao SH et al. Effects of exogenous sphinganine, sphingosine, and sphingosine-1-phosphate on relaxation and contraction of porcine thoracic aortic and pulmonary arterial rings. 2005 Toxicol. Sci. pmid:15829618
Yoo HS et al. Fumonisin inhibition of de novo sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cells. 1992 Toxicol. Appl. Pharmacol. pmid:1585377
Osuchowski MF et al. Endotoxin exposure alters brain and liver effects of fumonisin B1 in BALB/c mice: implication of blood brain barrier. 2005 Food Chem. Toxicol. pmid:15913876
Alkan S et al. Survival role of protein kinase C (PKC) in chronic lymphocytic leukemia and determination of isoform expression pattern and genes altered by PKC inhibition. 2005 Am. J. Hematol. pmid:15929099
Kariya Y et al. Products by the sphingosine kinase/sphingosine 1-phosphate (S1P) lyase pathway but not S1P stimulate mitogenesis. 2005 Genes Cells pmid:15938718
Touboul D et al. Fast fingerprinting by MALDI-TOF mass spectrometry of urinary sediment glycosphingolipids in Fabry disease. 2005 Anal Bioanal Chem pmid:15959771
Gelineau-van Waes J et al. Maternal fumonisin exposure and risk for neural tube defects: mechanisms in an in vivo mouse model. 2005 Birth Defects Res. Part A Clin. Mol. Teratol. pmid:15959874
Osuchowski MF and Sharma RP Fumonisin B1 induces necrotic cell death in BV-2 cells and murine cultured astrocytes and is antiproliferative in BV-2 cells while N2A cells and primary cortical neurons are resistant. 2005 Neurotoxicology pmid:16005069
Piva A et al. Activated carbon does not prevent the toxicity of culture material containing fumonisin B1 when fed to weanling piglets. 2005 J. Anim. Sci. pmid:16024715
Knapp P et al. Ceramides, sphinganine, sphingosine and acid sphingomyelinases in the human umbilical cord blood. 2005 Horm. Metab. Res. pmid:16034716
He Q and Sharma RP Inhibition of tumor necrosis factor alpha signaling by anti-tumor necrosis factor alpha antibodies and pentoxifylline is unable to prevent fumonisin hepatotoxicity in mice. 2005 Toxicon pmid:16054185
Tani M et al. Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets. 2005 J. Lipid Res. pmid:16061940
Uhlig S et al. 2-Amino-14,16-dimethyloctadecan-3-ol, a new sphingosine analogue toxin in the fungal genus Fusarium. 2005 Toxicon pmid:16084551
Alanko SM et al. Displacement of sterols from sterol/sphingomyelin domains in fluid bilayer membranes by competing molecules. 2005 Biochim. Biophys. Acta pmid:16126159
Sharma RP et al. Lupus-prone NZBWF1/J mice, defective in cytokine signaling, are resistant to fumonisin hepatotoxicity despite accumulation of liver sphinganine. 2005 Toxicology pmid:16159691
Yung BY et al. Interaction of antileukemia agents adriamycin and daunomycin with sphinganine on the differentiation of human leukemia cell line HL-60. 1992 Cancer Res. pmid:1617630
Voss KA et al. Toxic effects of fumonisin in mouse liver are independent of the peroxisome proliferator-activated receptor alpha. 2006 Toxicol. Sci. pmid:16221962
Liu K et al. Signalling functions for sphingolipid long-chain bases in Saccharomyces cerevisiae. 2005 Biochem. Soc. Trans. pmid:16246074
Soriano JM et al. Mechanism of action of sphingolipids and their metabolites in the toxicity of fumonisin B1. 2005 Prog. Lipid Res. pmid:16266752
Bu S et al. Dihydrosphingosine 1-phosphate stimulates MMP1 gene expression via activation of ERK1/2-Ets1 pathway in human fibroblasts. 2006 FASEB J. pmid:16278291
Saini HS et al. Novel role of sphingosine kinase 1 as a mediator of neurotrophin-3 action in oligodendrocyte progenitors. 2005 J. Neurochem. pmid:16313513
Waters CM et al. Cell migration activated by platelet-derived growth factor receptor is blocked by an inverse agonist of the sphingosine 1-phosphate receptor-1. 2006 FASEB J. pmid:16319133
Ndonye RM et al. Synthesis and evaluation of sphinganine analogues of KRN7000 and OCH. 2005 J. Org. Chem. pmid:16323834
Hamada M et al. Induction of endonuclease G-mediated apopotosis in human oral squamous cell carcinoma cells by protein kinase C inhibitor safingol. 2006 Apoptosis pmid:16374540
Wang E et al. Increases in serum sphingosine and sphinganine and decreases in complex sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium moniliforme. 1992 J. Nutr. pmid:1640265
Tardieu D et al. Effects of fumonisins on liver and kidney sphinganine and the sphinganine to sphingosine ratio during chronic exposure in ducks. 2006 Chem. Biol. Interact. pmid:16412405
Tran ST et al. Serum sphinganine and the sphinganine to sphingosine ratio as a biomarker of dietary fumonisins during chronic exposure in ducks. 2006 Chem. Biol. Interact. pmid:16413517
Campbell SE et al. Comparative effects of RRR-alpha- and RRR-gamma-tocopherol on proliferation and apoptosis in human colon cancer cell lines. 2006 BMC Cancer pmid:16417629
Missmer SA et al. Exposure to fumonisins and the occurrence of neural tube defects along the Texas-Mexico border. 2006 Environ. Health Perspect. pmid:16451860
Ahn EH and Schroeder JJ Sphinganine causes early activation of JNK and p38 MAPK and inhibition of AKT activation in HT-29 human colon cancer cells. 2006 Jan-Feb Anticancer Res. pmid:16475687
Ejsing CS et al. Collision-induced dissociation pathways of yeast sphingolipids and their molecular profiling in total lipid extracts: a study by quadrupole TOF and linear ion trap-orbitrap mass spectrometry. 2006 J Mass Spectrom pmid:16498600
Cai Y et al. A general, efficient and stereospecific route to sphingosine, sphinganines, phytosphingosines and their analogs. 2006 Org. Biomol. Chem. pmid:16525559
Berdyshev EV et al. De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells. 2006 Cell. Signal. pmid:16529909
Enomoto A et al. Dihydroceramide:sphinganine C-4-hydroxylation requires Des2 hydroxylase and the membrane form of cytochrome b5. 2006 Biochem. J. pmid:16571104
Voss KA et al. The role of tumor necrosis factor alpha and the peroxisome proliferator-activated receptor alpha in modulating the effects of fumonisin in mouse liver. 2006 Toxicology pmid:16574297
Lee EH et al. Dimethylsphingosine regulates intracellular pH and Ca(2+) in human monocytes. 2006 J. Pharmacol. Sci. pmid:16575153
Riley RT and Voss KA Differential sensitivity of rat kidney and liver to fumonisin toxicity: organ-specific differences in toxin accumulation and sphingoid base metabolism. 2006 Toxicol. Sci. pmid:16613836
Masukawa Y et al. Liquid chromatography-mass spectrometry for comprehensive profiling of ceramide molecules in human hair. 2006 J. Lipid Res. pmid:16639079
Jiang X and Han X Characterization and direct quantitation of sphingoid base-1-phosphates from lipid extracts: a shotgun lipidomics approach. 2006 J. Lipid Res. pmid:16682747
Vitkup D et al. Influence of metabolic network structure and function on enzyme evolution. 2006 Genome Biol. pmid:16684370
Eigenbrod S et al. Sphingosine kinase and sphingosine-1-phosphate regulate migration, endocytosis and apoptosis of dendritic cells. 2006 Immunol. Invest. pmid:16698674
Voss KA et al. Fumonisin concentration and ceramide synthase inhibitory activity of corn, masa, and tortilla chips. 2006 J. Toxicol. Environ. Health Part A pmid:16760143
Masukawa Y and Tsujimura H Highly sensitive determination of N-acyl dihydrosphingosine using liquid chromatography-electrospray ionization mass spectrometry. Application to human hair lipids. 2006 J Chromatogr A pmid:16781721
Denny PW et al. The protozoan inositol phosphorylceramide synthase: a novel drug target that defines a new class of sphingolipid synthase. 2006 J. Biol. Chem. pmid:16861742
Yoo HH et al. Liquid chromatography-tandem mass spectrometric determination of ceramides and related lipid species in cellular extracts. 2006 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:16891163
Byrdwell WC and Perry RH Liquid chromatography with dual parallel mass spectrometry and (31)P nuclear magnetic resonance spectroscopy for analysis of sphingomyelin and dihydrosphingomyelin. I. Bovine brain and chicken egg yolk. 2006 J Chromatogr A pmid:16938303
Cerantola V et al. Yeast sphingolipids do not need to contain very long chain fatty acids. 2007 Biochem. J. pmid:16987101
Dahm F et al. Distribution and dynamic changes of sphingolipids in blood in response to platelet activation. 2006 J. Thromb. Haemost. pmid:17010150
Andréani P and Gräler MH Comparative quantification of sphingolipids and analogs in biological samples by high-performance liquid chromatography after chloroform extraction. 2006 Anal. Biochem. pmid:17027903
Kim DH et al. Elevation of sphinganine 1-phosphate as a predictive biomarker for fumonisin exposure and toxicity in mice. 2006 J. Toxicol. Environ. Health Part A pmid:17060094
Ahn EH et al. Evaluation of sphinganine and sphingosine as human breast cancer chemotherapeutic and chemopreventive agents. 2006 Exp. Biol. Med. (Maywood) pmid:17060688
He Q et al. S-adenosylmethionine or 5'-methylthioadenosine are unable to prevent fumonisin B1 hepatotoxicity in mice despite increased oxidation in liver. 2006 Nov-Dec J Appl Toxicol pmid:17080400
Schmidt H et al. LC-MS/MS-analysis of sphingosine-1-phosphate and related compounds in plasma samples. 2006 Prostaglandins Other Lipid Mediat. pmid:17085324
Suzuki H et al. Inducible nitric oxide has protective effect on fumonisin B1 hepatotoxicity in mice via modulation of sphingosine kinase. 2007 Toxicology pmid:17095132
Giussani P et al. Sphingosine-1-phosphate and calcium signaling in cerebellar astrocytes and differentiated granule cells. 2007 Neurochem. Res. pmid:17151916
Delgado A et al. Chemical tools to investigate sphingolipid metabolism and functions. 2007 ChemMedChem pmid:17252619
Baranowski M et al. Pioglitazone induces de novo ceramide synthesis in the rat heart. 2007 Prostaglandins Other Lipid Mediat. pmid:17259076
Domijan AM et al. Fumonisin B(1): oxidative status and DNA damage in rats. 2007 Toxicology pmid:17291664
Cowart LA and Hannun YA Selective substrate supply in the regulation of yeast de novo sphingolipid synthesis. 2007 J. Biol. Chem. pmid:17322298
Groener JE et al. HPLC for simultaneous quantification of total ceramide, glucosylceramide, and ceramide trihexoside concentrations in plasma. 2007 Clin. Chem. pmid:17332150
Wei LL et al. Alkaline phosphatase activity during differentiation of the human promyelocytic leukemia cell line, HL-60. 1992 Biochem. Biophys. Res. Commun. pmid:1734863
Frgala T et al. A fluorescence microplate cytotoxicity assay with a 4-log dynamic range that identifies synergistic drug combinations. 2007 Mol. Cancer Ther. pmid:17363483
Tian YS et al. Stereoselective synthesis of L-threo-sphingosine, L-threo-sphinganine, D-threo-sphingosine, and D-threo-sphinganine via oxazoline formation and olefin cross-metathesis; potent protein kinase C inhibitor analogues. 2007 Arch. Pharm. Res. pmid:17366737
Don AS et al. Essential requirement for sphingosine kinase 2 in a sphingolipid apoptosis pathway activated by FTY720 analogues. 2007 J. Biol. Chem. pmid:17400555
Li S et al. basA regulates cell wall organization and asexual/sexual sporulation ratio in Aspergillus nidulans. 2007 Genetics pmid:17409079
Burenjargal M et al. Endogenous sphingolipid metabolites related to the growth in Sphingomonas chungbukensis. 2007 Arch. Pharm. Res. pmid:17424937